The role of Arg78 in the metabotropic glutamate receptor mGlu1 for agonist binding and selectivity

被引:27
|
作者
Jensen, AA
Sheppard, PO
O'Hara, PJ
Krogsgaard-Larsen, P
Bräuner-Osborne, H
机构
[1] Royal Danish Sch Pharm, Dept Med Chem, Neurosci Pharmabiotec Res Ctr, DK-2100 Copenhagen, Denmark
[2] Zymogenet Inc, Seattle, WA 98105 USA
关键词
mGlu(1) receptor; Arg(78); agonist binding; glutamic acid; quisqualic acid; mutagenesis;
D O I
10.1016/S0014-2999(00)00283-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabotropic glutamate receptors belong to family C of the G-protein coupled receptor superfamily. These receptors all possess large extracellular amino terminal domains, where agonist binding takes place. We have previously constructed a molecular model of the amino terminal domain of the mGlu(1) receptor based on a weak amino acid sequence similarity with a family of bacterial periplasmic binding proteins (PBPs). The residues Ser(165) and Thr(188) were demonstrated to be involved in agonist binding to the receptor. Here, we report that mutation of Arg(78) in the mGlu(1b) receptor to leucine or glutamate completely knocks out [H-3]quisqualic acid binding to the receptor. The constructed mutants, R78L and R78E, have also been characterized in a inositol phosphate assay. Here, the potency of (S)-glutamic acid and (S)-quisqualic acid was reduced 1000- and 100-fold, respectively, on R78L compared to the wild type (WT) receptor. (S)-Quisqualic acid was as potent on mutant R78E as it was on R78L, whereas (S)-glutamic acid was unable to activate R78E significantly at concentrations up to 10 mM. in conclusion, Arg(78) appears to be essential for agonist binding to the mGlu(1) receptor, most likely, through the formation of an ionic bond between its positively charged side chain and the distal acid group of the agonists. Furthermore, the different impact of the two mutations on (S)-glutamic acid and (S)-quisqualic acid potencies strongly indicates that while Arg(78) appears to be a common site of interaction for the agonists, the Group I subtype selectivity of (S)-quisqualic acid is probably determined by other residues in the amino terminal domain. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [31] Distinct role of mGlu1 and mGlu5 receptor activation in the development of the cerebellar cortex
    Catania, MV
    Bellomo, M
    Gerevini, VD
    Copani, A
    Giuffrida, R
    Nicoletti, F
    NEUROPHARMACOLOGY, 1999, 38 (10) : A10 - A10
  • [32] ROLE OF THE LARGE EXTRACELLULAR DOMAIN OF METABOTROPIC GLUTAMATE RECEPTORS IN AGONIST SELECTIVITY DETERMINATION
    TAKAHASHI, K
    TSUCHIDA, K
    TANABE, Y
    MASU, M
    NAKANISHI, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (26) : 19341 - 19345
  • [33] The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death
    Moroni, F
    Attucci, S
    Cozzi, A
    Meli, E
    Picca, R
    Scheideler, A
    Pellicciari, R
    Noe, C
    Sarichelou, I
    Pellegrini-Giampietro, DE
    NEUROPHARMACOLOGY, 2002, 42 (06) : 741 - 751
  • [34] Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators
    Samantha E. Yohn
    Daniel J. Foster
    Dan P. Covey
    Mark S. Moehle
    Jordan Galbraith
    Pedro M. Garcia-Barrantes
    Hyekyung P. Cho
    Michael Bubser
    Anna L. Blobaum
    Max E. Joffe
    Joseph F. Cheer
    Carrie K. Jones
    Craig W. Lindsley
    P. Jeffrey Conn
    Molecular Psychiatry, 2020, 25 : 2786 - 2799
  • [35] Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators
    Yohn, Samantha E.
    Foster, Daniel J.
    Covey, Dan P.
    Moehle, Mark S.
    Galbraith, Jordan
    Garcia-Barrantes, Pedro M.
    Cho, Hyekyung P.
    Bubser, Michael
    Blobaum, Anna L.
    Joffe, Max E.
    Cheer, Joseph F.
    Jones, Carrie K.
    Lindsley, Craig W.
    Conn, P. Jeffrey
    MOLECULAR PSYCHIATRY, 2020, 25 (11) : 2786 - 2799
  • [36] The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception
    Hu, Youmin
    Dong, Li
    Sun, Biying
    Guillon, Marlene A.
    Burbach, Leah R.
    Nunn, Philip A.
    Liu, Xingrong
    Vilenski, Olga
    Ford, Anthony P. D. W.
    Zhong, Yu
    Rong, Weifang
    NEUROSCIENCE LETTERS, 2009, 450 (01) : 12 - 17
  • [37] Metabotropic mGlu1 Receptor Regulation of Cortical Inhibition and Cognitive Function: Implications in Adolescent Cocaine Exposure
    Luessen, Deborah
    Gallinger, Isabel
    Wolfe, Brenna
    Conn, P. Jeffrey
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [38] ARG78 PARTICIPATES IN THE DNA-BINDING FUNCTION OF HIV-1 REVERSE-TRANSCRIPTASE
    SARAFIANOS, SG
    PANDEY, VN
    KAUSHIK, N
    MODAK, MJ
    PROTEIN ENGINEERING, 1995, 8 : 64 - 64
  • [39] Metabotropic mGlu1 Receptor Regulation of Cortical Inhibition and Cognitive Function: Implications in Adolescent Cocaine Exposure
    Luessen, Deborah
    Gallinger, Isabel
    Wolfe, Brenna
    Conn, P. Jeffrey
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 470 - 470
  • [40] Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
    Serena Notartomaso
    Cristina Zappulla
    Francesca Biagioni
    Milena Cannella
    Domenico Bucci
    Giada Mascio
    Pamela Scarselli
    Francesco Fazio
    Filippo Weisz
    Luana Lionetto
    Maurizio Simmaco
    Roberto Gradini
    Giuseppe Battaglia
    Michele Signore
    Aldamaria Puliti
    Ferdinando Nicoletti
    Molecular Brain, 6